Cooperative groups

DESCAR-T, National Registry for Patients with Hematological malignancies, Eligible for CAR T-Cell Therapy

DESCAR-T is a registry that brings together several cooperative and expert groups, all united in the fight against blood cancers, in both adult and pediatric populations.

IFM: Intergroupe Francophone du Myélome (Francophone Myeloma Intergroup)

The Intergroupe Francophone du Myélome is a cooperative group founded in 1994. It is the only French group working on myeloma. It includes 140 French centers and 33 Belgian centers. Its objective is to promote fundamental and therapeutic research through clinical trials aimed at improving the diagnosis and care management of myeloma.

The IFM was granted INCa labeling as Intergroup in December 2018. It contributes to the development of treatment recommendations as well as to the training of physicians and clinical research associates. The IFM is internationally recognized for the quality of its scientific production in the context of improvement of the overall survival of myeloma patients whose life expectancy has doubled in the last 10 years.

Source : Site web de l’IFM

GRAALL : Group for Research on Adult Acute Lymphoblastic Leukemia

The GRAALL is an “intergroup” resulting from the association of 3 groups:

  • LALA, a Franco-Belgian group
  • GOELAMS, a French group
  • SAKK, a Swiss group

The GRAALL currently has 74 hematological centers (57 in France, 7 in Belgium and 8 in Switzerland).

Composed of clinicians, biologists and clinical research assistants, the GRAALL (Group for Research in Adult Acute Lymphoblastic Leukemia) is interested in the treatment of Acute Lymphoblastic Leukemia (ALL) in adults.

Source : Site web du GRAALL

SFCE : Société Française de lutte contre les Cancers et les leucémies de l’Enfant et de l’adolescent (French Society for the Fight against Cancers and Leukemias in in Children and Adolescents)

The SFCE is an association of healthcare professionals (surgeons, radiotherapists, radiologists, pathologists, biologists, nurses, researchers) dedicated to improving the understanding, diagnosis, treatment and follow-up of cancers in children and adolescents.

The SFCE brings together 450 members from 30 French expert centers and supports research through its scientific council, pathology committees, scientific meetings and publications. The SFCE is also committed to providing a high standard of care for patients nationwide and to promoting education and training. Its missions are:

  • Organization of Care in pediatric oncology and hematology
  • Organization of Research in SFCE centers
  • Education and Training

Source : Site web de la SFCE

SFGM-TC : Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (Francophone Society of Marrow Transplantation and Cell Therapy)

The SFGM-TC works to develop scientific knowledge around hematopoietic stem cell transplantation and new approaches to cell therapy involving these cells and their derivatives. Its objective is to improve clinical outcomes and quality of care.

The SFGM-TC brings together more than 400 members from very different backgrounds but sharing a common desire, each in their own field of expertise, to facilitate access to the full range of hematopoietic stem cell transplantation options (still referred to as “marrow transplantation”) for children and adults who need them. Our goal is to bring forward and develop all aspects of this transplant which remains for a number of patients a hope of a cure.

Source : Site web de la SFGM-TC